Articles

Podcasts

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

Experts in gastroenterology share take-home messages for the management of ulcerative colitis.

Key Takeaways for Ulcerative Colitis Management

David P. Hudesman, MD; Marla Dubinsky, MD; Ellen J. Scherl, MD; and Miguel Regueiro, MD, provide advice for physicians treating patients with ulcerative colitis.

Clinical Pearls for the Treatment of Ulcerative Colitis

Drs David P. Hudesman, Ellen J. Scherl, Marla Dubinsky, and Miguel Regueiro, explore novel therapies in the pipeline and discuss approaches to optimizing sequencing and treatment selection for ulcerative colitis.

Future Treatment Paradigms in Ulcerative Colitis

Experts in gastroenterology discuss their approach to sequencing therapies in ulcerative colitis, considering safety, efficacy, and access to various treatment regimens and comment on challenges physicians may face when incorporating new therapies into clinical practice.

Sequencing Therapies in Ulcerative Colitis

Ellen J. Scherl, MD, reviews data from the phase 3 True North study evaluating the use of ozanimod as induction and maintenance therapy for moderate to severe ulcerative colitis, and the panel shares their experience with ozanimod in clinical practice.

Ozanimod in Ulcerative Colitis

Ellen J. Scherl, MD, leads a discussion on challenges faced with traditional ulcerative colitis treatments.

Challenges in UC Treatment

David P. Hudesman, MD, and expert panelists provide insight on optimizing the sequencing of therapies in ulcerative colitis and determining when a change in treatment is needed.

Switching Therapies in Ulcerative Colitis

Marla Dubinsky, MD, discusses the role of S1P receptor modulators and JAK inhibitors for the treatment of ulcerative colitis.

Role of JAK Inhibitors and S1P Receptor Modulators for UC Treatment

The mean values of stool scale form also increased in the kombucha cohort, while the control group remained unchanged.

Specialized Kombucha Drink Increases Stool Frequency in IBS Patients

David P. Hudesman, MD, reviews the use of anti-integrin and anti-interleukin therapies for the management of ulcerative colitis.

UC Treatment: Anti-integrin Antibodies and Anti-interleukins

On the HCPLive irritable bowel syndrome page, resources on the topics of medical news and expert insight into IBS can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBS, IBD, and more.

Irritable Bowel Syndrome

Latest News